Lannett Co., Inc (LCI)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

9000 STATE RD PHILADELPHIA, PA 19136

Lannett Company and subsidiaries develop, manufacture, package, market, and distribute finished dosage forms of drugs and manufacture active pharmaceutical ingredients. Co. manufactures solid oral dosage forms, including tablets and capsules, topical and oral solutions. All of Co.'s products manufactured and/or sold are prescription products. Co.'s products include those containing Levo, Digoxin tablets, products containing Butalbital, Morphine Sulfate Oral Solution and Cocaine Topical Solution. Co. has several generic products under development. These products are all orally-administered, topical, injectable and parenteral products designed to be generic equivalents to brand named drugs.

Data as of 2020-08-01
Market Cap240.088 Million Shares Outstanding40.351 Million Avg 30-day Volume862.27 Thousand
P/E Ratio Dividend Yield EPS-0.81
Price/Sales0.589 Price cash flow ratio5.3 Price free cash flow ratio26.1
Book Value7.7 Price to Tangible Book-2.74 Alpha-0.03
Short Interest Ratio14.44 % Short Interest to Float24.1 R-squared0.111875
BETA1.67135 52-week High/Low15.52 / 4.89 Stddev0.214991
View SEC Filings from LCI instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 145 37 (2.42%)
Aggregate 13F shares on 03/31/2020: 29.107 Million 12.712 Million
Aggregate 13F shares on 12/31/2019: 39.907 Million 22.047 Million
Percent change: -27.06% -42.34%
Funds creating new positions: 14 4
Funds Adding to an existing position: 54 13
Funds closing out their position: 31 10
Funds reducing their position: 47 16
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LCI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LCI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EHLINGER ROBERT VP AND CIO

  • Officer
70,191 2020-07-31 3

ABT JOHN CHIEF QUALITY AND OPERATIONS

  • Officer
87,015 2020-07-31 4

ISRAEL SAMUEL H CHIEF LEGAL OFFICER

  • Officer
120,888 2020-07-31 3

KOZLOWSKI JOHN VP OF FINANCE & CFO

  • Officer
100,025 2020-07-31 5

CREW TIMOTHY C CHIEF EXECUTIVE OFFICER

  • Officer
396,232 2020-07-31 5

CAVANAUGH MAUREEN SENIOR VICE PRESIDENT AND CCOO

  • Officer
118,120 2020-07-31 3

LANDIS G. MICHAEL PRINCIPAL ACCOUNTING OFFICER

  • Officer
37,294 2020-07-01 4

DRABIK DAVID A

  • Director
45,972 2020-05-19 1

TAVEIRA PAUL

  • Director
51,415 2020-05-19 1

LEPORE PATRICK G

  • Director
400,000 2020-05-14 1

PAONESSA ALBERT III

  • Director
45,945 2019-09-09 2

GALVAN MARTIN P FORMER VP OF FINANCE & CFO

  • Officer
102,409 2019-08-30 1

FARBER JEFFREY

  • Director
2,134,499 2019-07-19 0

CHAPMAN JOHN C

  • Director
46,019 2019-07-19 0

REWOLINSKI MELISSA

  • Director
5,785 2019-07-01 0

MAHER JAMES M.

  • Director
43,492 2018-07-20 0

FARBER DAVID

  • 10% Owner
No longer subject to file 2018-01-16 0

BEDROSIAN ARTHUR P CEO

  • Officer
  • Director
586,038 2017-11-22 0

SMITH KEVIN VP OF SALES AND MARKETING

  • Officer
18,458 2017-11-09 0

ARNOLD KRISTIN VP OF RESEARCH AND DEVELOPMENT

  • Officer
6,068 2017-02-27 0

DEDHIYA MAHENDRA CHIEF SCIENTIFIC AFFAIRS

  • Officer
2,976 2016-07-27 0

SCHRECK WILLIAM CHIEF OPERATING OFFICER

  • Officer
55,379 2015-07-22 0

BOGDA MICHAEL PRESIDENT

  • Officer
3,470 2015-07-22 0

FARBER PROPERTIES GROUP, LLC

  • 10% Owner
0 2015-07-17 0

DESAI ROHIT VP OF NEW PRODUCT STRATEGY

  • Officer
0 2015-06-01 0

SABO ERNEST VP, REGULATORY AND CCO

  • Officer
23,395 2014-12-08 0

SINCLAIR KENNETH

  • Director
41,250 2014-01-22 0

FARBER WILLIAM

  • Director
  • 10% Owner
5,398,423 2013-03-13 0

WEST RONALD A

  • Director
10,000 2012-07-17 0

WINKELMAN MYRON D

  • Director
33,500 2012-07-17 0

WERTHEIMER ALBERT I

  • Director
33,500 2012-07-17 0

RUCK KEITH RICHARD VP - FINANCE AND CFO

  • Officer
6,667 2011-06-14 0

KOVARY STEPHEN JOHN VP - OPERATIONS

  • Officer
0 2009-09-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CREW TIMOTHY C - Officer CHIEF EXECUTIVE OFFICER

2020-07-31 A 144,628 a 144,628 396,232.00 direct

CAVANAUGH MAUREEN - Officer SENIOR VICE PRESIDENT AND CCOO

2020-07-31 A 59,573 a 118,120 118,120.00 direct

KOZLOWSKI JOHN - Officer VP OF FINANCE & CFO

2020-07-31 A 37,121 a 37,121 100,025.00 direct

ABT JOHN - Officer CHIEF QUALITY AND OPERATIONS

2020-07-31 A 41,328 a 87,015 87,015.00 direct

CREW TIMOTHY C - Officer CHIEF EXECUTIVE OFFICER

2020-07-31 A 204,016 a 396,232 396,232.00 direct

ISRAEL SAMUEL H - Officer CHIEF LEGAL OFFICER

2020-07-31 A 39,725 a 39,725 120,888.00 direct

KOZLOWSKI JOHN - Officer VP OF FINANCE & CFO

2020-07-31 A 52,364 a 100,025 100,025.00 direct

EHLINGER ROBERT - Officer VP AND CIO

2020-07-31 A 15,895 a 15,895 70,191.00 direct

CAVANAUGH MAUREEN - Officer SENIOR VICE PRESIDENT AND CCOO

2020-07-31 A 42,231 a 42,231 118,120.00 direct

ISRAEL SAMUEL H - Officer CHIEF LEGAL OFFICER

2020-07-31 A 56,036 a 120,888 120,888.00 direct

ABT JOHN - Officer CHIEF QUALITY AND OPERATIONS

2020-07-31 A 29,298 a 29,298 87,015.00 direct

EHLINGER ROBERT - Officer VP AND CIO

2020-07-31 A 22,422 a 70,191 70,191.00 direct

EHLINGER ROBERT - Officer VP AND CIO

2020-07-30 F 538 $6.15 d 47,769 47,769.00 direct

ABT JOHN - Officer CHIEF QUALITY AND OPERATIONS

2020-07-30 F 492 $6.15 d 45,687 45,687.00 direct

ISRAEL SAMUEL H - Officer CHIEF LEGAL OFFICER

2020-07-30 F 1,145 $6.15 d 64,852 64,852.00 direct

KOZLOWSKI JOHN - Officer VP OF FINANCE & CFO

2020-07-30 F 758 $6.15 d 47,661 47,661.00 direct

KOZLOWSKI JOHN - Officer VP OF FINANCE & CFO

2020-07-29 F 2,040 $6.14 d 48,419 47,661.00 direct

CAVANAUGH MAUREEN - Officer SENIOR VICE PRESIDENT AND CCOO

2020-07-29 F 3,042 $6.14 d 58,547 58,547.00 direct

EHLINGER ROBERT - Officer VP AND CIO

2020-07-29 F 1,452 $6.14 d 48,307 47,769.00 direct

ABT JOHN - Officer CHIEF QUALITY AND OPERATIONS

2020-07-29 F 1,798 $6.14 d 46,179 45,687.00 direct

ISRAEL SAMUEL H - Officer CHIEF LEGAL OFFICER

2020-07-29 F 3,153 $6.14 d 65,997 64,852.00 direct

ISRAEL SAMUEL H - Officer CHIEF LEGAL OFFICER

2020-07-15 F 1,909 $5.14 d 69,150 69,150.00 direct

LANDIS G. MICHAEL - Officer PRINCIPAL ACCOUNTING OFFICER

2020-07-01 F 392 $7.07 d 37,294 37,294.00 direct

CREW TIMOTHY C - Officer CHIEF EXECUTIVE OFFICER

2020-06-30 J 1,478 $5.47 a 192,216 192,216.00 direct

EHLINGER ROBERT - Officer VP AND CIO

2020-06-30 J 1,422 $5.47 a 49,759 47,769.00 direct

ABT JOHN - Officer CHIEF QUALITY AND OPERATIONS

2020-06-30 J 873 $5.47 a 47,977 45,687.00 direct

ISRAEL SAMUEL H - Officer CHIEF LEGAL OFFICER

2020-06-30 J 812 $5.47 a 71,059 69,150.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments